These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34439399)

  • 21. Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes.
    Levin N; Kim SP; Marquardt CA; Vale NR; Yu Z; Sindiri S; Gartner JJ; Parkhurst M; Krishna S; Lowery FJ; Zacharakis N; Levy L; Prickett TD; Benzine T; Ray S; Masi RV; Gasmi B; Li Y; Islam R; Bera A; Goff SL; Robbins PF; Rosenberg SA
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Neoantigens in Cancer Immunotherapy.
    Zhu Y; Liu J
    Front Oncol; 2021; 11():682325. PubMed ID: 34513673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 24. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational Prediction and Validation of Tumor-Associated Neoantigens.
    Roudko V; Greenbaum B; Bhardwaj N
    Front Immunol; 2020; 11():27. PubMed ID: 32117226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines.
    Roesler AS; Anderson KS
    Methods Mol Biol; 2022; 2410():649-670. PubMed ID: 34914074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects.
    Gao L; Zhang A; Yang F; Du W
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting neoantigens for cancer immunotherapy.
    Zhao X; Pan X; Wang Y; Zhang Y
    Biomark Res; 2021 Jul; 9(1):61. PubMed ID: 34321091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.
    Yossef R; Tran E; Deniger DC; Gros A; Pasetto A; Parkhurst MR; Gartner JJ; Prickett TD; Cafri G; Robbins PF; Rosenberg SA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
    Borden ES; Buetow KH; Wilson MA; Hastings KT
    Front Oncol; 2022; 12():836821. PubMed ID: 35311072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.
    Nonomura C; Otsuka M; Kondou R; Iizuka A; Miyata H; Ashizawa T; Sakura N; Yoshikawa S; Kiyohara Y; Ohshima K; Urakami K; Nagashima T; Ohnami S; Kusuhara M; Mitsuya K; Hayashi N; Nakasu Y; Mochizuki T; Yamaguchi K; Akiyama Y
    Immunol Lett; 2019 Apr; 208():52-59. PubMed ID: 30880120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.
    Li J; Xiao Z; Wang D; Jia L; Nie S; Zeng X; Hu W
    Mol Cancer; 2023 Aug; 22(1):141. PubMed ID: 37649123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy.
    Nagaoka K; Sun C; Kobayashi Y; Kanaseki T; Tokita S; Komatsu T; Maejima K; Futami J; Nomura S; Udaka K; Nakagawa H; Torigoe T; Kakimi K
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.
    Mørk SK; Kadivar M; Bol KF; Draghi A; Westergaard MCW; Skadborg SK; Overgaard N; Sørensen AB; Rasmussen IS; Andreasen LV; Yde CW; Trolle T; Garde C; Friis-Nielsen J; Nørgaard N; Christensen D; Kringelum JV; Donia M; Hadrup SR; Svane IM
    Oncoimmunology; 2022; 11(1):2023255. PubMed ID: 35036074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
    Barajas A; Amengual-Rigo P; Pons-Grífols A; Ortiz R; Gracia Carmona O; Urrea V; de la Iglesia N; Blanco-Heredia J; Anjos-Souza C; Varela I; Trinité B; Tarrés-Freixas F; Rovirosa C; Lepore R; Vázquez M; de Mattos-Arruda L; Valencia A; Clotet B; Aguilar-Gurrieri C; Guallar V; Carrillo J; Blanco J
    J Transl Med; 2024 Jan; 22(1):14. PubMed ID: 38172991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy.
    Sng CCT; Kallor AA; Simpson BS; Bedran G; Alfaro J; Litchfield K
    Front Immunol; 2024; 15():1347542. PubMed ID: 38558815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer.
    Robertson J; Salm M; Dangl M
    Immunooncol Technol; 2019 Oct; 3():1-7. PubMed ID: 35757302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer.
    Brito Baleeiro R; Liu P; Chard Dunmall LS; Di Gioia C; Nagano A; Cutmore L; Wang J; Chelala C; Nyambura LW; Walden P; Lemoine N; Wang Y
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor neoantigens: Novel strategies for application of cancer immunotherapy.
    Guan H; Wu Y; Li LU; Yang Y; Qiu S; Zhao Z; Chu X; He J; Chen Z; Zhang Y; Ding H; Pan J; Pan Y
    Oncol Res; 2023; 31(4):437-448. PubMed ID: 37415744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma.
    Schaettler MO; Desai R; Wang AZ; Livingstone AJ; Kobayashi DK; Coxon AT; Bowman-Kirigin JA; Liu CJ; Li M; Bender DE; White MJ; Kranz DM; Johanns TM; Dunn GP
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36808076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.